» Articles » PMID: 6320906

Assessment of Selective Inhibition of Rat Cerebral Cortical Calcium-independent and Calcium-dependent Phosphodiesterases in Crude Extracts Using Deoxycyclic AMP and Potassium Ions

Overview
Specialties Biochemistry
Biophysics
Date 1984 Mar 1
PMID 6320906
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of various inhibitors on the activity of calcium-independent and calcium-dependent phosphodiesterases from rat cerebral cortex were examined. While the agents varied greatly in their relative potency, each was found to be approximately equipotent in inhibiting the calcium-dependent hydrolysis of either cyclic AMP or cyclic GMP. In contrast, the inhibitors displayed a marked substrate specificity for the calcium-independent enzyme with ratios of IC50 values for inhibition of cyclic GMP hydrolysis when compared to cyclic AMP hydrolysis in decreasing order being: ZK 62711 (much greater than 100) greater than Ro 20-1724 (much greater than 25) papaverine (13) greater than 7-benzyl IBMX (4) greater than quercetin and kaempferol (2). The differential selectivity of the inhibitors for the two enzymes was most pronounced for ZK 62711 and Ro 20-1724 which were at least 25-100-times more potent in inhibiting the calcium-independent hydrolysis of cyclic AMP when compared to the calcium-dependent hydrolysis of cyclic AMP. In contrast, 7-benzyl IBMX, kaempferol and quercetin were 8-100-times more effective as inhibitors of cyclic GMP hydrolysis by the calcium-dependent phosphodiesterase while 7-benzyl IBMX and trimazosin displayed a similar enzyme selectivity using cyclic AMP as substrate. With the exception of papaverine, all agents were competitive inhibitors of the calcium-dependent phosphodiesterase. The type of inhibition observed with the calcium-independent enzyme was dependent on the substrate employed. The specificity of potassium ions in inhibiting the activity of the calcium-dependent phosphodiesterase and deoxycyclic AMP in inhibiting the calcium-independent enzyme was found to provide a convenient means to assess the effects of agents on these activities in crude extracts of cerebral cortex.

Citing Articles

Roflumilast and aquaporin-2 regulation in rat renal inner medullary collecting duct.

Umejiego E, Wang Y, Knepper M, Chou C Physiol Rep. 2017; 5(2).

PMID: 28108651 PMC: 5269416. DOI: 10.14814/phy2.13121.


Phosphodiesterase 4-targeted treatments for autoimmune diseases.

Kumar N, Goldminz A, Kim N, Gottlieb A BMC Med. 2013; 11:96.

PMID: 23557064 PMC: 3616808. DOI: 10.1186/1741-7015-11-96.


Local delivery of rolipram, a phosphodiesterase-4-specific inhibitor, augments bone morphogenetic protein-induced bone formation.

Tokuhara Y, Wakitani S, Imai Y, Nomura C, Hoshino M, Yano K J Bone Miner Metab. 2009; 28(1):17-24.

PMID: 19554392 DOI: 10.1007/s00774-009-0103-5.


Kaempferol stimulates large conductance Ca2+ -activated K+ (BKCa) channels in human umbilical vein endothelial cells via a cAMP/PKA-dependent pathway.

Xu Y, Leung G, Wong P, Vanhoutte P, Man R Br J Pharmacol. 2008; 154(6):1247-53.

PMID: 18493242 PMC: 2483388. DOI: 10.1038/bjp.2008.194.


Kaempferol enhances endothelium-independent and dependent relaxation in the porcine coronary artery.

Xu Y, Yeung D, Man R, Leung S Mol Cell Biochem. 2006; 287(1-2):61-7.

PMID: 16699727 DOI: 10.1007/s11010-005-9061-y.